The mother of a seven-year-old with a life-threatening blood disorder says despite treatments being the same as cancer, they ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

Background: REV1 is a member of the translesion synthesis DNA polymerase Y family. It is an essential player in a variety ... JNK and p38 signaling, kinases, PI3K/MTOR signaling, and RTK signaling ...

The therapy is a PI3K inhibitor, which selectively targets a type of protein called PI3K. "We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep ...

Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings from the phase ...

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical ...

Ashlee is an insurance editor, journalist and business professional with an MBA and more than 17 years of hands-on experience in both business and personal finance. She is passionate about ...